GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Medicure Inc (TSXV:MPH) » Definitions » E10

Medicure (TSXV:MPH) E10 : C$0.29 (As of Dec. 2023)


View and export this data going back to 1999. Start your Free Trial

What is Medicure E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medicure's adjusted earnings per share data for the three months ended in Dec. 2023 was C$-0.150. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is C$0.29 for the trailing ten years ended in Dec. 2023.

During the past 12 months, Medicure's average E10 Growth Rate was 11.50% per year. During the past 3 years, the average E10 Growth Rate was -16.60% per year. During the past 5 years, the average E10 Growth Rate was -13.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of Medicure was 54.50% per year. The lowest was -21.20% per year. And the median was -1.70% per year.

As of today (2024-04-30), Medicure's current stock price is C$1.07. Medicure's E10 for the quarter that ended in Dec. 2023 was C$0.29. Medicure's Shiller PE Ratio of today is 3.69.

During the past 13 years, the highest Shiller PE Ratio of Medicure was 125.67. The lowest was 1.52. And the median was 4.48.


Medicure E10 Historical Data

The historical data trend for Medicure's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medicure E10 Chart

Medicure Annual Data
Trend May14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.50 0.50 0.23 0.26 0.29

Medicure Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.26 0.26 0.28 0.29 0.29

Competitive Comparison of Medicure's E10

For the Drug Manufacturers - Specialty & Generic subindustry, Medicure's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medicure's Shiller PE Ratio Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Medicure's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medicure's Shiller PE Ratio falls into.



Medicure E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medicure's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=-0.15/125.4675*125.4675
=-0.150

Current CPI (Dec. 2023) = 125.4675.

Medicure Quarterly Data

per share eps CPI Adj_EPS
201308 -0.040 97.261 -0.052
201311 -0.040 97.182 -0.052
201402 0.010 98.051 0.013
201405 -0.090 99.394 -0.114
201408 0.100 99.315 0.126
201503 0.010 99.789 0.013
201506 0.030 100.500 0.037
201509 -0.020 100.421 -0.025
201512 0.100 99.947 0.126
201603 0.050 101.054 0.062
201606 0.030 102.002 0.037
201609 0.120 101.765 0.148
201612 1.360 101.449 1.682
201703 -0.330 102.634 -0.403
201706 0.080 103.029 0.097
201709 -0.290 103.345 -0.352
201712 2.940 103.345 3.569
201803 0.080 105.004 0.096
201806 0.090 105.557 0.107
201809 -0.030 105.636 -0.036
201812 0.100 105.399 0.119
201903 -0.180 106.979 -0.211
201906 -0.060 107.690 -0.070
201909 -0.040 107.611 -0.047
201912 -1.040 107.769 -1.211
202003 -0.140 107.927 -0.163
202006 0.002 108.401 0.002
202009 -0.100 108.164 -0.116
202012 -0.410 108.559 -0.474
202103 -0.100 110.298 -0.114
202106 -0.060 111.720 -0.067
202109 -0.090 112.905 -0.100
202112 0.190 113.774 0.210
202203 0.050 117.646 0.053
202206 -0.060 120.806 -0.062
202209 0.110 120.648 0.114
202212 0.040 120.964 0.041
202303 0.030 122.702 0.031
202309 0.010 125.230 0.010
202312 -0.150 125.468 -0.150

Add all the adjusted EPS together and divide 10 will get our e10.


Medicure  (TSXV:MPH) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Medicure's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=1.07/0.29
=3.69

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Medicure was 125.67. The lowest was 1.52. And the median was 4.48.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medicure E10 Related Terms

Thank you for viewing the detailed overview of Medicure's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Medicure (TSXV:MPH) Business Description

Traded in Other Exchanges
Address
2 - 1250 Waverley Street, Winnipeg, MB, CAN, R3T 6C6
Medicure Inc is a biopharmaceutical company. It is involved in the research, clinical development, and commercialization of human therapeutics for the United States hospital market. Further, it also operates a specialty pharmacy in the United States of America. The company's present focus is the sale and marketing of its cardiovascular products, AGGRASTAT, ZYPITAMAG, and developing its e-commerce and mail order pharmaceutical business. The company operates in two segments namely, Marketing and distribution of commercial products and, Retail and mail order pharmacy. The majority of the company's revenue is generated from the marketing and distribution of the commercial products segment.

Medicure (TSXV:MPH) Headlines

No Headlines